On Oct. 6 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On Oct. 5 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On Oct. 4 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

The Food and Drug Administration issued its weekly Enforcement Report for Oct. 4 that lists the status of recalls and field corrections for food, drugs, biologics and devices. The report covers both domestic and foreign firms.

The Food and Drug Administration released a guidance document to clarify FDA and Environmental Protection Agency jurisdiction over mosquito-related products. According to the guidance document, FDA’s definition of drug “does not include articles intended to function as pesticides by preventing, destroying, repelling, or mitigating mosquitoes for population control purposes.” Rather, “products intended to reduce the population of mosquitoes (for example, by killing them at some point in their life cycle, or by interfering with their reproduction or development)” are examples of pesticides regulated by EPA, the guidance document said. “FDA encourages sponsors of mosquito-related products, other than those that are intended to prevent, destroy, repel, or mitigate mosquitoes by controlling a mosquito population, to contact FDA early in the development process,” it said. In cases of jurisdictional questions, FDA and EPA will consult with each other and may suggest a joint meeting with the product’s sponsor, FDA said.

The Food and Drug Administration and the Food Safety and Inspection Service should work closer together on drug residue testing methods for imported seafood, the Government Accountability Office said in a report released Oct. 2. Seafood raised on farms is often treated with drugs to prevent disease and increase survival rates, but residue from some of those drugs can cause cancer or allergic reactions, the FDA has said. The GAO recommended that the FDA pursue formal agreements with seafood exporting countries that include commitments to drug residue testing.

On Oct. 2 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On Sept. 29 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On Sept. 28 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

The Food and Drug Administration is proposing to extend compliance dates by about one and a half years for two recent final rules changing requirements for nutrition facts labeling for food. Under the proposed rule, compliance with the new regulations, which would revise the information required and formatting on nutrition facts labels and increase recommended serving sizes (see 1605200021), would be required by January 2020 for most food manufacturers, and January 2021 for small businesses. The requirements currently take effect in July 2018 and July 2019, respectively. The extension comes in response to concerns from industry about its “ability to update all products by the original compliance dates and the importance of obtaining clarification from the FDA on a number of technical issues relating to the final rules,” FDA said. Comments on the proposed rule are due Nov. 1. FDA says it will “exercise enforcement discretion with respect to the current” compliance dates until it completes its consideration of the extension.